Department of Health and Human Services June 19, 2009 – Federal Register Recent Federal Regulation Documents

National Toxicology Program (NTP); Office of Liaison, Policy and Review; Meeting of the Scientific Advisory Committee on Alternative Toxicological Methods (SACATM): Amended Notice
Document Number: E9-14502
Type: Notice
Date: 2009-06-19
Agency: Department of Health and Human Services
This notice announces the availability of public video casting of the SACATM meeting on June 25-26, 2009. The meeting will be held at the Hilton Arlington Hotel, 950 North Stafford Street, Arlington, VA 22203 and video cast through a link on the SACATM Web site (https:// ntp.niehs.nih.gov/go/7441). Information regarding the meeting was announced in the Federal Register (74 FR 19562) published on April 29, 2009 and available on the NTP Web site (https://ntp.niehs.nih.gov/go/ 32822).
Proposed Information Collection Activity; Comment Request
Document Number: E9-14482
Type: Notice
Date: 2009-06-19
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Clinical Trials Transformation Initiative (U19)
Document Number: E9-14436
Type: Notice
Date: 2009-06-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of grant funds to support the Clinical Trials Transformation Initiative (CTTI). The goal of CTTI is to support modernization of the clinical trial enterprise by identifying practices that will enhance human subject protection, boost the quality of information derived from clinical trials, and make the research process more efficient.
Reimbursement of Travel and Subsistence Expenses toward Living Organ Donation Eligibility Guidelines
Document Number: E9-14425
Type: Notice
Date: 2009-06-19
Agency: Department of Health and Human Services, Health Resources and Services Administration
This notice finalizes an amendment to the eligibility guidelines proposed on March 4, 2009 in the Federal Register (74 FR 9407). The purpose of this notice was to solicit comments on the amendment to the Program Eligibility Guidelines proposed by HRSA concerning the Reimbursement of Travel and Subsistence Expenses Program follow-up period.
Pandemic Influenza Antivirals-Amendment
Document Number: E9-14412
Type: Notice
Date: 2009-06-19
Agency: Department of Health and Human Services
Amendment to declaration pursuant to section 319F-3 of the Public Health Service Act (42 U.S.C. 247d-6d) to provide targeted liability protections for pandemic countermeasures based on the Acting Secretary's April 26 determination, under section 319F-3(b) of the Act, that the risk that the spread of H1N1 swine influenza viruses (now known as 2009 H1N1 Influenza A, or 2009 H1N1 influenza) and resulting disease constitutes a public health emergency.
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: E9-14411
Type: Notice
Date: 2009-06-19
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Office of Child Support Enforcement
Document Number: E9-14363
Type: Notice
Date: 2009-06-19
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
The Office of Child Support Enforcement (OCSE) in the Administration for Children and Families (ACF) hereby gives notice to the public that a matching requirement of five percent (5%) will be administratively imposed upon awards made under competitions governed by the following ``Section 1115'' funding opportunities in Fiscal Year 2009.
Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction; Buprenorphine and Buprenorphine Combination; Approved Opioid Treatment Medications Use
Document Number: E9-14286
Type: Proposed Rule
Date: 2009-06-19
Agency: Department of Health and Human Services
This proposed rule amends the Federal opioid treatment program regulations by modifying the dispensing requirements for buprenorphine and buprenorphine combination products approved by FDA for opioid dependence and used in federally certified and registered opioid treatment programs. Opioid treatment programs that use these products in the treatment of opioid dependence will adhere to all other Federal treatment standards established for methadone.
Submission for OMB Review; Comment Request
Document Number: E9-14181
Type: Notice
Date: 2009-06-19
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.